Country websites

We continue to shape the future of the dialysis industry.

Outlook 2025

Outlook 2025 unchanged and as published on February 25, 2025

  Revenue 2024 Outlook 2025
(at constant currencies)
Revenue EUR 19.336 million Positive to a low-single digit percent growth
Operating income EUR 1.797 million High-teens to high-twenties percent growth

 

Revenue and operating income, as referred to in the outlook, are both on a constant currency basis and excluding special items. Special items will be provided as separate KPI (“Operating income excl. special items”) to capture effects that are unusual in nature and have not been foreseeable or not foreseeable in size or impact at the time of providing the outlook. These items are excluded to ensure comparability of the figures presented with the Company’s financial targets which have been defined excluding special items.

Growth rates as shown above are year-on-year basis

2030 Aspirations 

Operating income margin aspirations by 2030

  2024 2030e
Fresenius Medical Care Group 9.3% Mid-teens
     
Care Delivery 11.4% Mid-teens
Care Enablement 6.0% Mid-teens
Value-Based Care -1.6% Low-single digit

 

Operating income excluding special items; margin in percent of revenue

Assumptions to our margin aspirations include: broadly stable currency exchange rates; no further escalating geopolitical conflicts, tariffs and trade barriers; no major disruptions, such as, but not limited to, changes in regulatory environment and reimbursement systems, disruptions in financial markets, of global supply chains and at our manufacturing sites as well as new or potential export/import restrictions across key markets.

FME Segment Revenue Assumptions | Outlook 2025 and 2030 Aspirations

Contact us for further information

+49 6172 268 87 95

Related Content